Previous close | 0.3500 |
Open | 2.6000 |
Bid | 1.1000 |
Ask | 4.6000 |
Strike | 65.00 |
Expiry date | 2024-05-17 |
Day's range | 2.6000 - 2.6000 |
Contract range | N/A |
Volume | |
Open interest | 59 |
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
Dyne (DYN) gains 28% after reporting positive new data from two separate ongoing mid to late-stage studies evaluating DYNE-101 and DYNE-251 for different muscle disease indications.
PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January 2024 on the annual renewal of the conditional approval of Translarna.